Premium
Diagnostic accuracy of a new non‐invasive enzyme immunoassay for detecting Helicobacter pylori in stools after eradication therapy
Author(s) -
Shunji Ishihara,
Takekazu Kaji,
Akira Kawamura,
M.A.K. Rumi,
Hiroshi Satō,
Toshihiko Okuyama,
Kyoichi Adachi,
Ryuki Fukuda,
Makoto Watanabe,
Tomoyuki Hashimoto,
K. Hirakawa,
Yumi Matsushima,
Tsutomu Chiba,
Yoshikazu Kinoshita
Publication year - 2000
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1046/j.1365-2036.2000.00736.x
Subject(s) - medicine , helicobacter pylori , immunoassay , spirillaceae , helicobacter infections , gastroenterology , immunology , gastritis , antibody
Background: Helicobacter pylori eradication therapy has been commonly performed for patients with peptic ulcer. An inexpensive, reliable, non‐invasive test would be useful for evaluation of the effectiveness of eradication therapy. Aim: To evaluate the diagnostic potential of a new non‐invasive enzyme immunoassay (HpSA) for H. pylori antigen in stools. Methods: A total of 112 peptic ulcer patients with H. pylori infection (82 male, 30 female; age range 22–81 years, mean 54 years) received a course of eradication therapy. Four weeks after the end of the therapy, stool samples were collected from all patients and tested using the HpSA. The diagnostic accuracy of the HpSA EIA was evaluated in comparison with the results of a 13 C‐urea breath test. Results: The diagnostic sensitivity of HpSA EIA after eradication therapy was 90%, the specificity 98%, the positive predictive value 82% and the negative predictive value 99%. Conclusion: The HpSA stool test is potentially useful for the diagnosis of H. pylori infection 4 weeks after the end of eradication therapy.